Alnylam Pharmaceuticals Inc’s filing revealed that its Director SHARP PHILLIP A unloaded Company’s shares for reported $4.54 million on Feb 29 ’24. In the deal valued at $151.34 per share,30,000 shares were sold. As a result of this transaction, SHARP PHILLIP A now holds 0 shares worth roughly $0.0.
Then, Greenstreet Yvonne sold 2,932 shares, generating $455,357 in total proceeds. Upon selling the shares at $155.31, the Chief Executive Officer now owns 48,128 shares.
Before that, Garg Pushkal sold 574 shares. Alnylam Pharmaceuticals Inc shares valued at $89,145 were divested by the CMO & EVP Dev & Med Affairs at a price of $155.30 per share. As a result of the transaction, Garg Pushkal now holds 8,666 shares, worth roughly $1.27 million.
Goldman downgraded its Alnylam Pharmaceuticals Inc [ALNY] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Wolfe Research’s analysts, who began to cover the stock in mid February with a ‘”a Peer perform”‘ rating. Wells Fargo began covering ALNY with “an Equal weight” recommendation on December 08, 2023. Wells Fargo started covering the stock on December 08, 2023. It rated ALNY as “an Equal weight”.
Price Performance Review of ALNY
On Tuesday, Alnylam Pharmaceuticals Inc [NASDAQ:ALNY] saw its stock fall -0.66% to $146.72. Over the last five days, the stock has lost -5.89%. Alnylam Pharmaceuticals Inc shares have fallen nearly -23.35% since the year began. Nevertheless, the stocks have fallen -29.23% over the past one year. While a 52-week high of $218.88 was reached on 01/09/24, a 52-week low of $143.52 was recorded on 02/15/24. SMA at 50 days reached $153.95, while 200 days put it at $174.68. A total of 0.35 million shares were traded, compared to the trading of 0.43 million shares in the previous session.
Levels Of Support And Resistance For ALNY Stock
The 24-hour chart illustrates a support level at 145.67, which if violated will result in even more drops to 144.63. On the upside, there is a resistance level at 148.10. A further resistance level may holdings at 149.49. The Relative Strength Index (RSI) on the 14-day chart is 39.12, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -4.03, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 94.67%. Stochastics %K at 9.68% indicates the stock is a buying.
